Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Matthew L Sherman. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Matthew L Sherman har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
EVP & Chief Medical Officer | 0 | |
US:PIRS / Pieris Pharmaceuticals, Inc. | Director | 40 000 |
Director | 13 889 | |
US:PULM / Pulmatrix, Inc. | Director | 15 000 |
US:XLRN / Acceleron Pharma Inc | EVP & Chief Medical Officer | 68 767 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Matthew L Sherman. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp PULM / Pulmatrix, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i PULM / Pulmatrix, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2018-04-03 | PULM | Sherman Matthew L | 20 000 | 1 333 | 69 | 120 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i PULM / Pulmatrix, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Matthew L Sherman som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-11 |
|
4 | NA |
Deciphera Pharmaceuticals, Inc.
Common Stock |
U - Other | −72 261 | 0 | −100,00 | ||||
2024-06-11 |
|
4 | NA |
Deciphera Pharmaceuticals, Inc.
Common Stock |
D - Sale to Issuer | −72 029 | 72 261 | −49,92 | ||||
2024-06-11 |
|
4 | NA |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 34 157 | 144 290 | 31,01 | ||||
2024-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 615 | 108 739 | −2,35 | 15,62 | −40 840 | 1 698 253 | |
2024-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 17 275 | 111 354 | 18,36 | ||||
2024-01-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 435 | 94 079 | −2,52 | 14,47 | −35 234 | 1 361 295 | |
2023-12-14 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 792 | 96 514 | −2,81 | 15,37 | −42 905 | 1 483 140 | |
2023-12-14 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 8 244 | 99 306 | 9,05 | ||||
2023-10-31 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 360 | 90 628 | −2,54 | 12,02 | −28 362 | 1 089 131 | |
2023-10-31 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 8 244 | 92 988 | 9,73 | ||||
2023-10-04 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 942 | 84 744 | −3,36 | 12,68 | −37 305 | 1 074 554 | |
2023-06-21 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −1 655 | 87 686 | −1,85 | 14,40 | −23 835 | 1 262 836 | |
2023-02-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −971 | 88 145 | −1,09 | 15,10 | −14 661 | 1 330 901 | |
2023-02-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 16 488 | 89 116 | 22,70 | ||||
2023-01-19 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 403 | 72 628 | −3,20 | 21,24 | −51 043 | 1 542 713 | |
2022-10-05 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 587 | 74 297 | −3,36 | 18,73 | −48 455 | 1 391 583 | |
2022-06-21 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −1 768 | 76 884 | −2,25 | 10,75 | −19 006 | 826 503 | |
2022-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −984 | 76 790 | −1,27 | 9,05 | −8 905 | 694 950 | |
2022-01-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 82 000 | 82 000 | |||||
2022-01-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 20 500 | 77 774 | 35,79 | ||||
2021-12-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 82 265 | 82 265 | |||||
2021-12-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 11 100 | 57 274 | 24,04 | ||||
2021-10-06 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −2 659 | 46 029 | −5,46 | 33,17 | −88 199 | 1 526 782 | |
2021-06-29 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2021-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 49 900 | 49 900 | |||||
2021-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 11 100 | 48 386 | 29,77 | ||||
2021-02-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
S - Sale | −132 | 37 286 | −0,35 | 48,87 | −6 451 | 1 822 167 | |
2020-12-11 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy) |
M - Exercise | −207 | 147 096 | −0,14 | ||||
2020-12-11 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 207 | 37 418 | 0,56 | 34,43 | 7 127 | 1 288 302 | |
2020-11-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to buy) |
M - Exercise | −2 697 | 147 303 | −1,80 | ||||
2020-11-18 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 2 697 | 37 211 | 7,81 | 34,43 | 92 858 | 1 281 175 | |
2020-10-06 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 632 | 34 128 | −7,16 | 51,15 | −134 618 | 1 745 535 | |
2020-06-25 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2020-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | −10 520 | 10 520 | −50,00 | ||||
2020-02-20 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 1 760 | 36 760 | 5,03 | ||||
2020-01-28 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2019-10-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 150 000 | 150 000 | |||||
2019-10-17 |
|
4 | DCPH |
Deciphera Pharmaceuticals, Inc.
Common Stock |
A - Award | 35 000 | 35 000 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 13 889 | 13 889 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
D - Sale to Issuer | −27 777 | 0 | −100,00 | ||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 18 506 | 18 506 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 13 218 | 13 218 | |||||
2019-08-02 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
D - Sale to Issuer | −63 447 | 0 | −100,00 | ||||
2019-05-20 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 15 000 | 15 000 | |||||
2019-05-14 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 25 000 | 25 000 | |||||
2019-01-29 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2018-10-25 |
|
4 | PIRS |
PIERIS PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
2018-06-06 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 124 000 | 124 000 | |||||
2018-05-25 |
|
4 | (NLNK) |
NEWLINK GENETICS CORP
Stock Option (Right to Buy) |
A - Award | 27 777 | 27 777 | |||||
2018-04-05 |
|
4 | PULM |
Pulmatrix, Inc.
Series A Warrant (right to buy) |
P - Purchase | 20 000 | 20 000 | |||||
2018-04-05 |
|
4 | PULM |
Pulmatrix, Inc.
Series B Warrant (right to buy) |
P - Purchase | 20 000 | 20 000 | |||||
2018-04-05 |
|
4 | PULM |
Pulmatrix, Inc.
Common Stock |
P - Purchase | 20 000 | 20 000 | |||||
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −900 | 68 767 | −1,29 | 39,04 | −35 136 | 2 684 664 |
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 700 | 69 667 | −5,04 | 38,28 | −141 636 | 2 666 853 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 033 | 73 367 | −2,70 | 43,33 | −88 090 | 3 178 992 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 300 | 75 400 | −2,96 | 42,40 | −97 520 | 3 196 960 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 77 700 | −0,38 | 40,86 | −12 258 | 3 174 822 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −150 | 78 000 | −0,19 | 39,91 | −5 986 | 3 112 980 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 78 150 | −2,01 | 39,24 | −62 784 | 3 066 606 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −16 650 | 79 750 | −17,27 | 38,32 | −638 028 | 3 056 020 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −8 000 | 0 | −100,00 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −16 000 | 96 400 | −14,23 | 32,00 | −512 000 | 3 084 800 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 8 000 | 112 400 | 7,66 | 7,12 | 56 960 | 800 288 |
2017-03-22 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 4 400 | 4 400 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 47 300 | 47 300 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 7 900 | 104 400 | 8,19 | ||||
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 96 500 | −1,63 | 27,62 | −44 192 | 2 665 330 |
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 98 100 | −0,41 | 26,81 | −10 724 | 2 630 061 |
2016-10-03 |
|
4 | PULM |
Pulmatrix, Inc.
Stock Option (Right to Buy) |
A - Award | 8 800 | 8 800 | |||||
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −17 000 | 8 000 | −68,00 | ||||
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −1 896 | 0 | −100,00 | ||||
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 17 000 | 98 500 | 20,86 | 7,12 | 121 040 | 701 320 | |
2016-08-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 1 896 | 81 500 | 2,38 | 5,28 | 10 011 | 430 320 | |
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −6 000 | 1 896 | −75,99 | ||||
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 000 | 79 604 | 8,15 | 5,28 | 31 680 | 420 309 | |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 604 | 7 896 | −36,83 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −3 500 | 0 | −100,00 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −5 896 | 0 | −100,00 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −20 207 | 73 604 | −21,54 | 34,89 | −705 022 | 2 568 044 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 793 | 93 811 | −5,82 | 34,20 | −198 121 | 3 208 336 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 604 | 99 604 | 4,85 | 5,28 | 24 309 | 525 909 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 500 | 95 000 | 3,83 | 3,88 | 13 580 | 368 600 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 896 | 91 500 | 6,89 | 5,08 | 29 952 | 464 820 |
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −14 000 | 5 896 | −70,37 | |||
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −23 920 | 85 604 | −21,84 | 32,00 | −765 440 | 2 739 328 |
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 14 000 | 109 524 | 14,66 | 5,08 | 71 120 | 556 382 |
2016-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 080 | 95 524 | −2,13 | 32,00 | −66 560 | 3 056 768 |
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 36 000 | 36 000 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 000 | 97 604 | 6,55 | ||||
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 8 500 | −5,56 | 23,94 | −11 970 | 203 490 |
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 9 000 | −7,22 | 22,69 | −15 883 | 204 210 |
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 400 | 91 604 | −2,55 | 23,93 | −57 432 | 2 192 084 |
2015-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 400 | 94 004 | −2,49 | 22,66 | −54 384 | 2 130 131 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 9 700 | −3,96 | 34,96 | −13 984 | 339 112 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 96 404 | −0,21 | 34,93 | −6 986 | 3 367 392 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 96 604 | −0,31 | 33,55 | −10 065 | 3 241 064 |
2015-09-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 100 | 96 904 | −1,12 | 32,22 | −35 442 | 3 122 247 |
2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 46 000 | 98 004 | 88,45 | ||||
2015-08-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −20 000 | 3 500 | −85,11 | ||||
2015-08-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 20 000 | 52 004 | 62,49 | 3,88 | 77 600 | 201 776 | |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 19 896 | −7,44 | |||
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 0 | −100,00 | |||
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 10 100 | −1,94 | 31,69 | −6 338 | 320 069 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 10 100 | −1,94 | 31,69 | −6 338 | 320 069 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 10 300 | −7,21 | 30,99 | −24 792 | 319 197 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 11 100 | −3,48 | 31,95 | −12 780 | 354 645 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 400 | 32 204 | −4,17 | 31,00 | −43 400 | 998 324 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 33 604 | 5,00 | 5,08 | 8 128 | 170 708 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 210 | 32 004 | −3,64 | 31,60 | −38 236 | 1 011 326 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 790 | 33 214 | −7,75 | 30,83 | −86 016 | 1 023 988 |
2015-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −800 | 21 496 | −3,59 | |||
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 4 000 | −50,00 | |||
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 11 500 | −1,71 | 33,22 | −6 644 | 382 030 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 11 700 | −7,87 | 32,31 | −32 310 | 378 027 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 32 004 | −2,44 | 33,22 | −26 576 | 1 063 173 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 800 | 32 804 | 2,50 | 5,08 | 4 064 | 166 644 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 32 004 | −0,31 | 32,74 | −3 274 | 1 047 811 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 900 | 32 104 | −10,83 | 32,29 | −125 931 | 1 036 638 |
2015-07-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 22 296 | −6,70 | |||
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 8 000 | −33,33 | |||
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 12 700 | −3,05 | 31,07 | −12 428 | 394 589 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 13 100 | −7,09 | 31,57 | −31 570 | 413 567 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 600 | 32 004 | −14,89 | 31,57 | −176 792 | 1 010 366 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 37 604 | 4,44 | 5,08 | 8 128 | 191 028 |
2015-06-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 23 896 | −6,28 | |||
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 12 000 | −25,00 | |||
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 400 | 14 100 | −9,03 | 32,20 | −45 080 | 454 020 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 600 | 32 004 | −14,89 | 32,41 | −181 496 | 1 037 250 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 37 604 | 4,44 | 5,08 | 8 128 | 191 028 |
2015-05-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 16 000 | −20,00 | |||
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 15 500 | −6,06 | 33,50 | −33 500 | 519 250 |
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 000 | 32 004 | −11,11 | 33,53 | −134 120 | 1 073 094 |
2015-04-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 36 004 | 12,50 | 0,48 | 1 920 | 17 282 |
2015-04-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −12 000 | 23 500 | −33,80 | ||||
2015-04-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 12 000 | 32 004 | 59,99 | 3,88 | 46 560 | 124 176 | |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −800 | 25 496 | −3,04 | |||
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 20 000 | −16,67 | |||
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 16 500 | −1,20 | 41,21 | −8 242 | 679 965 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 16 700 | −0,60 | 41,60 | −4 160 | 694 720 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −900 | 16 800 | −5,08 | 41,13 | −37 017 | 690 984 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 20 004 | −3,85 | 41,21 | −32 968 | 824 365 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 800 | 20 804 | 4,00 | 5,08 | 4 064 | 105 684 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −721 | 20 004 | −3,48 | 41,63 | −30 015 | 832 767 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 279 | 20 725 | −13,66 | 41,07 | −134 669 | 851 176 |
2015-03-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 15 000 | 15 000 | |||||
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 26 296 | −5,74 | |||
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 24 000 | −14,29 | |||
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 17 700 | −1,67 | 41,38 | −12 414 | 732 426 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 18 000 | −3,74 | 40,63 | −28 441 | 731 340 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 18 700 | −2,09 | 40,92 | −16 368 | 765 204 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 20 004 | −7,41 | 40,21 | −64 336 | 804 361 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 21 604 | 8,00 | 5,08 | 8 128 | 109 748 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 20 004 | −0,99 | 42,07 | −8 414 | 841 568 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 001 | 20 204 | −4,72 | 41,40 | −41 441 | 836 446 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 799 | 21 205 | −11,66 | 40,66 | −113 807 | 862 195 |
2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 28 000 | −12,50 | |||
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 600 | 27 896 | −5,42 | |||
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 19 100 | −4,98 | 41,60 | −41 600 | 794 560 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 20 100 | −1,95 | 41,70 | −16 680 | 838 170 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 486 | 24 004 | −9,38 | 41,81 | −103 940 | 1 003 607 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 514 | 22 490 | −6,31 | 41,23 | −62 422 | 927 263 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 600 | 20 004 | −7,41 | 41,78 | −66 848 | 835 767 |
2015-01-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 600 | 21 604 | 8,00 | 5,08 | 8 128 | 109 748 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 32 000 | −11,11 | |||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 20 500 | −4,65 | 40,19 | −40 190 | 823 895 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 20 004 | −0,99 | 40,60 | −8 120 | 812 162 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 800 | 20 204 | −15,83 | 40,13 | −152 494 | 810 787 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 24 004 | 20,00 | 0,48 | 1 920 | 11 522 |
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −2 000 | 35 500 | −5,33 | ||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 2 000 | 20 004 | 11,11 | 3,88 | 7 760 | 77 616 | |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 29 496 | −11,94 | |||
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 21 500 | −2,27 | 43,73 | −21 865 | 940 195 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 22 000 | −2,22 | 43,16 | −21 580 | 949 520 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 065 | 18 004 | −5,58 | 43,88 | −46 732 | 790 016 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 935 | 19 069 | −13,34 | 43,32 | −127 144 | 826 069 |
2014-12-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 22 004 | 22,22 | 5,08 | 20 320 | 111 780 |
2014-12-12 |
|
4/A | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 13 922 | −0,71 | 32,23 | −3 223 | 448 706 |
2014-12-12 |
|
4/A | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 900 | 14 022 | −11,93 | 31,47 | −59 793 | 441 272 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 082 | 36 000 | −10,18 | |||
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −300 | 22 500 | −1,32 | 34,51 | −10 353 | 776 475 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −700 | 22 800 | −2,98 | 33,42 | −23 394 | 761 976 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −907 | 19 940 | −4,35 | 34,54 | −31 328 | 688 728 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 175 | 20 847 | −13,22 | 33,54 | −106 490 | 699 208 |
2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 082 | 24 022 | 20,47 | 0,48 | 1 959 | 11 531 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 504 | 33 496 | −4,30 | |||
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −2 414 | 0 | −100,00 | |||
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −400 | 23 500 | −1,67 | 33,70 | −13 480 | 791 950 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −600 | 23 900 | −2,45 | 32,64 | −19 584 | 780 096 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 317 | 19 940 | −10,41 | 33,59 | −77 828 | 669 785 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 601 | 22 257 | −6,71 | 32,43 | −51 920 | 721 795 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 504 | 23 858 | 6,73 | 5,08 | 7 640 | 121 199 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 414 | 22 354 | 12,11 | 1,80 | 4 345 | 40 237 |
2014-10-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 24 500 | −3,92 | 29,12 | −29 120 | 713 440 |
2014-10-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 918 | 19 940 | −16,42 | 29,10 | −114 014 | 580 254 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 082 | 2 414 | −62,84 | |||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 25 500 | −0,78 | 30,41 | −6 082 | 775 455 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −800 | 25 700 | −3,02 | 29,27 | −23 416 | 752 239 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 193 | 23 858 | −4,76 | 30,28 | −36 124 | 722 420 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 889 | 25 051 | −10,34 | 29,17 | −84 272 | 730 738 |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 082 | 27 940 | 17,11 | 1,80 | 7 348 | 50 292 |
2014-09-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 26 500 | −3,64 | 25,50 | −25 500 | 675 750 |
2014-09-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −4 000 | 23 858 | −14,36 | 25,47 | −101 880 | 607 663 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 000 | 6 496 | −38,11 | |||
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 27 500 | −3,51 | 25,79 | −25 790 | 709 225 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −200 | 27 858 | −0,71 | 26,40 | −5 280 | 735 451 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 800 | 28 058 | −11,93 | 25,80 | −98 040 | 723 896 |
2014-09-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 31 858 | 14,36 | 1,80 | 7 200 | 57 344 |
2014-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 28 500 | −1,72 | 30,00 | −15 000 | 855 000 |
2014-08-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 27 858 | −6,70 | 29,53 | −59 060 | 822 647 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −4 316 | 10 496 | −29,14 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −1 684 | 40 081 | −4,03 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 29 000 | −4,92 | 29,82 | −44 730 | 864 780 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 29 858 | −0,33 | 30,25 | −3 025 | 903 204 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −5 900 | 29 958 | −16,45 | 29,77 | −175 643 | 891 850 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 316 | 35 858 | 13,68 | 1,80 | 7 769 | 64 544 |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 684 | 31 542 | 5,64 | 0,48 | 808 | 15 140 |
2014-08-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −8 000 | 14 812 | −35,07 | ||||
2014-08-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 8 000 | 29 858 | 36,60 | 1,80 | 14 400 | 53 744 | |
2014-07-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | −10 000 | 22 812 | −30,48 | ||||
2014-07-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 21 858 | 84,33 | 1,80 | 18 000 | 39 344 | |
2014-07-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 30 500 | −1,61 | 25,50 | −12 750 | 777 750 |
2014-07-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −33 | 11 858 | −0,28 | 26,78 | −884 | 317 557 |
2014-07-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 967 | 11 891 | −14,19 | 26,39 | −51 909 | 313 803 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 000 | 41 765 | −12,56 | |||
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −499 | 31 000 | −1,58 | 29,46 | −14 701 | 913 260 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 001 | 31 499 | −3,08 | 28,77 | −28 799 | 906 226 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −3 094 | 13 858 | −18,25 | 29,39 | −90 933 | 407 287 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 906 | 16 952 | −14,63 | 28,55 | −82 966 | 483 980 |
2014-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 000 | 19 858 | 43,30 | 0,48 | 2 880 | 9 532 |
2014-06-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 32 500 | −1,52 | 34,13 | −17 065 | 1 109 225 |
2014-06-20 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 000 | 13 858 | −12,61 | 34,49 | −68 980 | 477 962 |
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | −6 000 | 47 765 | −11,16 | |||
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 33 000 | −4,35 | 33,25 | −49 875 | 1 097 250 |
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 000 | 15 858 | −27,45 | 33,23 | −199 380 | 526 961 |
2014-06-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 000 | 21 858 | 37,84 | 0,48 | 2 880 | 10 492 |
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | −6 000 | 53 765 | −10,04 | |||
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −6 000 | 15 858 | −27,45 | 30,97 | −185 820 | 491 122 |
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 000 | 21 858 | 37,84 | 0,48 | 2 880 | 10 492 |
2014-05-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 500 | 34 500 | −4,17 | 30,99 | −46 485 | 1 069 155 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −500 | 36 000 | −1,37 | 31,68 | −15 840 | 1 140 480 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −100 | 15 858 | −0,63 | 32,23 | −3 223 | 511 103 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 900 | 15 958 | −10,64 | 31,47 | −59 793 | 502 198 |
2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 000 | 36 500 | −2,67 | 35,75 | −35 750 | 1 304 875 |
2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −1 936 | 15 922 | −10,84 | 36,08 | −69 851 | 574 466 |
2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | −2 064 | 17 858 | −10,36 | 35,64 | −73 561 | 636 459 |
2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 | |||||
2013-09-18 | 3 | XLRN |
ACCELERON PHARMA INC
Common Stock |
19 922 | ||||||||
2013-09-18 | 3 | XLRN |
ACCELERON PHARMA INC
Common Stock |
37 500 |